Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Total Non-Current Liabilities (2020 - 2022)

NovaBridge Biosciences (NBP) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $32.6 million as the latest value for Q4 2022.

  • Quarterly Total Non-Current Liabilities rose 18.25% to $32.6 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $32.6 million through Dec 2022, up 18.25% year-over-year, with the annual reading at $32.6 million for FY2022, 18.25% up from the prior year.
  • Total Non-Current Liabilities for Q4 2022 was $32.6 million at NovaBridge Biosciences, up from $27.6 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $32.6 million in Q4 2022, with the low at $1.6 million in Q4 2020.
  • Average Total Non-Current Liabilities over 3 years is $20.6 million, with a median of $27.6 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities surged 1572.79% in 2021, then rose 18.25% in 2022.
  • Over 3 years, Total Non-Current Liabilities stood at $1.6 million in 2020, then soared by 1572.79% to $27.6 million in 2021, then increased by 18.25% to $32.6 million in 2022.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $32.6 million, $27.6 million, and $1.6 million for Q4 2022, Q4 2021, and Q4 2020 respectively.